J Am Pharm Assoc (2003). 2019 Nov-Dec;59(6):857-861. doi: 10.1016/j.japh.2019.08.010. Epub 2019 Oct 1.
To determine the prevalence and predictors of receiving a smoking cessation medication prescription at discharge.
Retrospective analysis of ongoing Human Studies Committee-approved clinical trial data at large tertiary care center, The University of Kansas Medical Center. Patients included were smokers over 18, either Spanish or English speaking, those admitted between October 1, 2016 through May 31, 2018. Other eligibility criteria include access to a telephone or mobile phone, not currently be pregnant or breastfeeding, have no significant co-morbidity that precludes participation (acute, life-threatening illness, and communication barriers such as tracheal tube or altered mental status). Those included in this analysis were those randomized into the trial who expressed interest in receiving a smoking cessation medication prescription at discharge.
Two hundred fourteen patients were recommended a prescription by their smoking cessation counselor, 88 patients (41.12%) were approved a prescription at discharge. Out of those approved, 50.70 (14.05 SD) was the average age, 12.84 (8.47 SD) was the average number of cigarettes used per day, 47 patients (53.41%) were White, 49 patients (55.68%) were admitted through the emergency department, 55 patients (62.50%) had used smoking cessation medication in the past, 49 patients (55.68%) had used inpatient smoking cessation, 36 patients (40.91%) had Medicaid. A binary logistic regression determined to show insurance status (P = 0.042) and use of inpatient smoking cessation medication use (P < 0.001) as statistically significant predictors of receiving a prescription at discharge.
It was determined that among the population recommended for medication, 41.12% actually received a prescription at discharge. The variables of "health insurance status" and "use of inpatient smoking cessation medication" demonstrated to be predictors of receiving a prescription. It is important to further study this as many patients rely on a prescription to afford these medications that are useful in a quit attempt.
确定出院时开具戒烟药物处方的流行率和预测因素。
对堪萨斯大学医学中心大型三级保健中心正在进行的人类研究委员会批准的临床试验数据进行回顾性分析。患者为年龄在 18 岁以上的吸烟者，讲西班牙语或英语，于 2016 年 10 月 1 日至 2018 年 5 月 31 日期间入院。其他入选标准包括有电话或手机，目前未怀孕或哺乳，没有严重的合并症妨碍参与（急性、危及生命的疾病和沟通障碍，如气管插管或意识状态改变）。本分析纳入了那些在试验中随机分组并表示有兴趣在出院时获得戒烟药物处方的患者。
214 名患者被戒烟顾问建议开具处方，88 名患者（41.12%）在出院时获得批准。在获得批准的患者中，平均年龄为 50.70（14.05 标准差），平均每天吸烟量为 12.84（8.47 标准差），47 名患者（53.41%）为白人，49 名患者（55.68%）通过急诊入院，55 名患者（62.50%）过去曾使用过戒烟药物，49 名患者（55.68%）使用过住院戒烟治疗，36 名患者（40.91%）有医疗补助。二项逻辑回归确定保险状况（P=0.042）和使用住院戒烟药物（P<0.001）为出院时开具处方的统计学显著预测因素。
在建议药物治疗的人群中，有 41.12%的人实际上在出院时获得了处方。“健康保险状况”和“使用住院戒烟药物”这两个变量被证明是开具处方的预测因素。进一步研究这一点很重要，因为许多患者依赖处方来负担这些在戒烟尝试中有用的药物。
